888-536-7697 ext. 3103
oncologysupply.com
☰
˟
LOGIN FAILED - Invalid User Name / Password. Please Try Again
You have been logged out. Thank you
This is a warning feedback message
Pricing Alert

Oncology Resources

 Access branded clinical information sponsored by Bristol-Myers Squibb.
Pricing Alert

Lower Drug Prices

 Barry Fortner, PhD, recently commented on over 150 concepts laid out by the HHS Blueprint for Lowering Drug Pricing. Read his letter here.
Pricing Alert

Physician Compare

 CMS is adding star ratings to the Physician Compare website in 2018. Learn how to manage your practice’s reputation to keep, and attract new, patients.
Pricing Alert

Precision vs Personalized

 The first post in our series of Precision Medicine blogs discusses the difference between precision and personalized medicine. Learn more.
Pricing Alert

2017 MIPS Performance

 CMS announced that clinicians who participated in 2017 MIPS can now review final performance feedback, including payment adjustment info for 2019.
Pricing Alert

New AMA President

 Congratulations to Barbara McAneny, MD, CEO of New Mexico Cancer Center, who was recently inaugurated as president of the American Medical Association.
Pricing Alert

Data's Effect on Reputation

 2016 scores are available in the Physician Compare Database. Learn what this data means for your practice.
Pricing Alert

Changes from 2017-2018

 Our Quality Reporting Engagement Group reported the top 10 differences in MIPS reporting from 2017 to 2018. Learn more.
Pricing Alert

MIPS Topped-Out Measures

 Understand and address "topped-out measures" as your practice conducts its 2018 MIPS reporting.
Pricing Alert

Top Trends in Cancer Care

 Barry Fortner, PhD, discusses the top trends influencing the future of affordable cancer care and how community oncology practices can adapt.
Pricing Alert

MIPS Cost Category

 Cost focuses on resources used to care for patients and Medicare payments for care given. Learn about the one report you need.
Pricing Alert

Patient-Centered Care

 We reviewed the roles of evidence-based medicine, patient navigation and access to care in a transition to patient-centered care. Learn about other key areas.
Breaking News
Exciting data for ERLEADA (apalutamide)
Clinical results for IMFINZI (durvalumab)
TAGRISSO (osimertinib) New Indication
Now Approved: New BRAF-mutant metastatic melanoma treatment
Treating Relapsed/Refractory MCL
OPDIVO: Medicare and Reimbursement Update
View More
Videos
The Provider Perspective
Video 1 of 6
The Provider Perspective
AMERISOURCEBERGEN RESOURCES
Community Counts
Advocacy and legislative support
 Innovation Cancer
Technology, marketing, and consulting
 US Bioservices
Specialty pharmacy solutions
 OncologySupply
Chemo and supportive care orders